Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 6 minute read Healthcare Industry News GRAIL stock surges 14% after $110m Samsung deal to expand Galleri test in Asia GRAIL stock jumps 14% after Samsung's $110M investment and Asia commercialization deal for its Galleri cancer test. Learn how investors are reacting. byVenkateshOctober 16, 2025